Citations 26

Leukoencephalopathies Associated with Macrocephaly

Seminars in Neurology | March 16, 2012 | Volume: 32 | Issue: 01 | Pages: 034-041

10.1055/s-0032-1306384 | PMID 22422204

Inherited Leukoencephalopathies

Seminars in Neurology | March 16, 2012 | Volume: 32 | Issue: 01 | Pages: 003-008

10.1055/s-0032-1306380 | PMID 22422201

Clinical Approach to Leukoencephalopathies

Seminars in Neurology | March 15, 2012 | Volume: 32 | Issue: 01 | Pages: 029-033

10.1055/s-0032-1306383 | PMID 22518894

RESPONSE TO IMMUNOTHERAPY IN A 20-MONTH-OLD BOY WITH ANTI-NMDA RECEPTOR ENCEPHALITIS

Neurology | May 10, 2010 | Volume: 74 | Issue: 19 | Pages: 1550-1551

10.1212/wnl.0b013e3181dd41a1 | PMID 20458074

Genetic and Clinical Heterogeneity in eIF2B-Related Disorder

Journal of Child Neurology | February 8, 2008 | Volume: 23 | Issue: 2 | Pages: 205-215

10.1177/0883073807308705 | PMID 18263758

Eukaryotic initiation factor 2B (eIF2B)-related disorders are heritable white matter disorders with a variable clinical phenotype (including vanishing white matter disease and ovarioleukodystrophy) and an equally heterogeneous genotype. We report 9 novel mutations in the EIF2B genes in our subject population, increasing the number of known mutations to more than 120. Using homology modeling, we have analyzed the impact of novel mutations on the 5 subunits of the eIF2B protein. Although recurrent mutations have been found at CpG dinucleotides in the EIF2B genes, the high incidence of private or low frequency mutations increases the challenge of providing rapid genetic confirmation of this disorder, and limits the application of EIF2B screening in cases of undiagnosed leukodystrophy.
Steroid-Responsive Encephalopathy Associated With Hashimoto’s Thyroiditis in an Adolescent With Chronic Hallucinations and Depression: Case Report and Review

Pediatrics | August 14, 2004 | Volume: 112 | Issue: 3 | Pages: 686-690

10.1542/peds.112.3.686 | PMID 12949305